In summary, the present study identifies sets of new genes that respond differentially to IL-4 in CLL depending on ZAP-70 expression and NFκB activation, contributing to the understanding of the anti-apoptotic response to IL-4 of CLL. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.